EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrating Next‐Generation Sequencing Into Routine Molecular Diagnosis of Inherited Coagulation Factor Deficiencies: Real‐World Data From Spanish Patients

Nina Borràs iD, Natàlia Comes, Lorena Ramírez, Rafael Parra, Carmen Altisent, Álvaro Lorenzo-Vizcaya, Cristina Marzo-Alonso, Maria-Fernanda López-Fernández, Mariana Canaro, María Falcón-Rodríguez, Ángela Cortes-Vidal, Mario A Rios de Paz und 6 weitere

Haemophilia · 2025

DOI: 10.1111/hae.70075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Haemophilia, 2025. Verfasst von Nina Borràs und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratori Coagulopaties Congènites, Banc de Sang i Teixits, Barcelona, Spain. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Coagulation Protein Disorders, Molecular Diagnostic Techniques, Blood Coagulation Disorders, Inherited. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Spanish Ministerio de Economía y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII), 2015 Baxalta ConfiHe Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Inherited coagulation factor deficiencies (ICFD) result from plasma protein deficiencies, impacting blood coagulation cascade and leading to haemorrhagic diathesis. Advancements in next‐generation sequencing (NGS) technology have enabled high‐throughput methods for molecular ICFD diagnosis. However, detailed descriptions of clinical applications and routine laboratory experiences in this field remain scarce.

Aim

This study presents the results from a real‐world experience using an NGS‐based gene panel for routine molecular diagnosis, applied to more than 500 ICFD patients in Spain.

Methods

A custom NGS gene panel targeting 22 ICFD‐related genes was validated using 20 patients with known variants. Subsequently, the panel was applied to 515 ICFD patients from 28 Spanish hospitals. Structural variants were detected by multiplex ligation‐dependent probe amplification.

Results

Among the 515 patients analysed, 402 had complete phenotypic data specified in the genetic study form, 83 had incomplete data, and 30 were potential haemophilia carriers. Identification disease‐causing variant rates were 69%, 58% and 53%, respectively. Candidate variants were identified in 74% of cases. A total of 460 variants across 18 genes were identified, 302 unique variants, with 37% being novel disease‐causing variants.

Conclusion

This study represents the largest analysis of ICFD patients conducted in Spain, providing significant insights into the molecular epidemiology of these disorders. It underscores the critical role of NGS in routine clinical practice while addressing challenges faced by genetic laboratories. The findings highlight a growing shift among haematologists towards integrating genetic studies early in diagnostic workflows alongside phenotypic assessments to enhance the accuracy and efficiency of ICFD diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingCoagulation Protein DisordersMolecular Diagnostic TechniquesBlood Coagulation Disorders, InheritedHumansSpainMaleFemaleAdultMiddle AgedAdolescentChildChild, PreschoolYoung AdultInfant

Stichwörter der Autor:innen

NGSbleeding disordersgene panelhigh‐throughput DNA sequencinginherited coagulation factor deficienciesmolecular diagnosis

Autor:innen und Institutionen

  • Laboratori Coagulopaties Congènites, Banc de Sang i Teixits, Barcelona, Spain.
  • Medicina Transfusional, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain.
  • FEA Hematología y Hemoterapia, Hospital Universitario Lucus Augusti (HULA), Lugo, Spain.
  • Servicio de Hematología, Hospital Universitario Arnau de Vilanova, Lleida, Spain.
  • Servicio de Hematología, Complexo Hospitalario Universitario A Coruña, INIBIC, A Coruña, Spain.
  • Servicio de Hematología y Hemoterapia, Hospital Universitario Son Espases, Palma, Spain.

ORCID-Profile: Nina Borràs, Perla Bandini

Förderung

  • Spanish Ministerio de Economía y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII)
  • 2015 Baxalta ConfiHe Award

Zitieren

APA

Borràs, N., Comes, N., Ramírez, L., Parra, R., Altisent, C., Lorenzo-Vizcaya, Á., Marzo-Alonso, C., López-Fernández, M. F., Canaro, M., Falcón-Rodríguez, M., Cortes-Vidal, Á., Rios de Paz, M. A., Rodríguez-García, J. A., Moreto-Quintana, A., Bandini, P., Hobeich, C., Corrales, I., & Vidal, F. (2025). Integrating Next‐Generation Sequencing Into Routine Molecular Diagnosis of Inherited Coagulation Factor Deficiencies: Real‐World Data From Spanish Patients. Haemophilia. https://doi.org/10.1111/hae.70075

Vancouver

Borràs N, Comes N, Ramírez L, Parra R, Altisent C, Lorenzo-Vizcaya Á, et al. Integrating Next‐Generation Sequencing Into Routine Molecular Diagnosis of Inherited Coagulation Factor Deficiencies: Real‐World Data From Spanish Patients. Haemophilia. 2025. doi:10.1111/hae.70075

BibTeX
@article{Borrs2025,
  author = {Borràs, Nina and Comes, Natàlia and Ramírez, Lorena and Parra, Rafael and Altisent, Carmen and Lorenzo-Vizcaya, Álvaro and Marzo-Alonso, Cristina and López-Fernández, Maria-Fernanda and Canaro, Mariana and Falcón-Rodríguez, María and Cortes-Vidal, Ángela and Rios de Paz, Mario A and Rodríguez-García, José Antonio and Moreto-Quintana, Ana and Bandini, Perla and Hobeich, Carlos and Corrales, Irene and Vidal, Francisco},
  title = {Integrating Next‐Generation Sequencing Into Routine Molecular Diagnosis of Inherited Coagulation Factor Deficiencies: Real‐World Data From Spanish Patients},
  journal = {Haemophilia},
  year = {2025},
  doi = {10.1111/hae.70075}
}
Kostenlos starten →